| Kelly A Heine, CRNA | |
|
201 Ridge St, Suite 102, Council Bluffs, IA 51503-4643 | |
| (712) 322-5565 | |
| (712) 322-5566 |
| Full Name | Kelly A Heine |
|---|---|
| Gender | Female |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 201 Ridge St, Council Bluffs, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497073761 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 62406 (Nebraska) | Primary |
| Entity Name | Hypnos Anesthesia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699837682 PECOS PAC ID: 1951320597 Enrollment ID: O20051114000444 |
News Archive
Medicity, Inc. today announced that IASIS Healthcare went live with the Medicity Novo Grid solution in two (Florida and Utah) of its six regions. The solution enables IASIS to exchange health information electronically with providers connected on the Grid – whether the providers use an electronic health record (EHR) or operate a paper-based practice.
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.
CSIRO scientists have developed a test to identify unsafe stem cells. It is the first safety test specifically for human induced pluripotent stem cells - as published today in the international journal Stem Cells.
Today, leukemia patients who have struggled with cancer therapy resistance and intolerance will now have more options thanks to targeted drug therapy. Such new treatment options are due, in part, to a rapid increase in journal and patent publications following the discovery of Gleevec, as reported by Chemical Abstracts Service (CAS), the world's authority for chemical information.
In the Huffington Post's "World" blog, writer Marianne Schnall interviews Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, "about why she considers family planning such a vital issue, how she views the role of philanthropy, her excitement over a new crowdfunding platform she helped launch called Catapult, and the many ways she says giving has enriched her life."
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kelly A Heine, CRNA Po Box 1988, Council Bluffs, IA 51502-1988 Ph: (712) 322-5565 | Kelly A Heine, CRNA 201 Ridge St, Suite 102, Council Bluffs, IA 51503-4643 Ph: (712) 322-5565 |
News Archive
Medicity, Inc. today announced that IASIS Healthcare went live with the Medicity Novo Grid solution in two (Florida and Utah) of its six regions. The solution enables IASIS to exchange health information electronically with providers connected on the Grid – whether the providers use an electronic health record (EHR) or operate a paper-based practice.
Bayer HealthCare announced today that patient enrollment is underway for RESORCE (Regorafenib after Sorafenib in Patients with Hepatocellular Carcinoma), an international Phase III trial to evaluate the efficacy and safety of Stivarga (regorafenib) tablets for the treatment of patients with hepatocellular carcinoma who have progressed on Nexavar (sorafenib) tablets, an anticancer medicine for the treatment of patients with unresectable HCC.
CSIRO scientists have developed a test to identify unsafe stem cells. It is the first safety test specifically for human induced pluripotent stem cells - as published today in the international journal Stem Cells.
Today, leukemia patients who have struggled with cancer therapy resistance and intolerance will now have more options thanks to targeted drug therapy. Such new treatment options are due, in part, to a rapid increase in journal and patent publications following the discovery of Gleevec, as reported by Chemical Abstracts Service (CAS), the world's authority for chemical information.
In the Huffington Post's "World" blog, writer Marianne Schnall interviews Melinda Gates, co-chair of the Bill & Melinda Gates Foundation, "about why she considers family planning such a vital issue, how she views the role of philanthropy, her excitement over a new crowdfunding platform she helped launch called Catapult, and the many ways she says giving has enriched her life."
› Verified 5 days ago
Brianne Buge, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St Ste 102, Council Bluffs, IA 51503 Phone: 712-396-6095 Fax: 402-884-3740 | |
James L Hawes, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 25 Main Pl, Suite 425, Council Bluffs, IA 51503 Phone: 712-322-5565 Fax: 712-322-5566 | |
Wendy Marie Schwery, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 402-778-9738 Fax: 402-334-2849 | |
Amanda J Nastase, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 800 Mercy Dr, Council Bluffs, IA 51503 Phone: 712-328-5000 Fax: 402-334-2849 | |
Kara D Dostal, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St, Suite 21, Council Bluffs, IA 51503 Phone: 712-322-5565 Fax: 712-322-5566 | |
Rachel Jean Pittner, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 201 Ridge St Ste 102, Council Bluffs, IA 51503 Phone: 712-396-4359 Fax: 712-396-7888 |